Russell DeKelver
Inventor
Stats
- 11 US patents issued
- 20 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 11 US Patents Issued
- 20 US Applications Filed
- 384 Total Citation Count
- Oct 24, 2022 Most Recent Filing
- Apr 24, 2008 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
SANGAMO BIOSCIENCES, INC. | 2
2 | 2010
2013 |
SANGAMO THERAPEUTICS, INC. | 2
1 4 4 4 4 | 2008
2009 2011 2014 2015 2016 |
DOW AGROSCIENCES LLC | 2
2 | 2010
2013 |
Inventor Addresses
Address | Duration |
---|---|
Brisbane, CA, US | Mar 02, 23 - Oct 19, 23 |
Daly City, CA | Dec 04, 08 - Dec 04, 08 |
Daly City, CA, US | Feb 07, 12 - Sep 02, 14 |
La Jolla, CA, US | Oct 22, 09 - Jun 02, 15 |
Richmond, CA, US | Jun 05, 14 - Aug 02, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A01H: | NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 4 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2023/0330,195 | 2023 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE | 0 |
2023/0067,653 | 2023 | ENGINEERED TARGET SPECIFIC NUCLEASES | 0 |
11401512 | 2022 | Engineered target specific nucleases | 0 |
2019/0241,877 | 2019 | ENGINEERED TARGET SPECIFIC NUCLEASES | 4 |
10196651 | 2019 | Methods and compositions for treatment of a genetic condition | 10 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.